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Introduction
Adenocarcinoma in situ of the uterine cervix is a 
precursor of cervical adenocarcinoma and may 
coexist with both adenocarcinoma and high-
grade squamous dysplasia. Its incidence has been 
increasing, even in developed countries (Liu et al., 
2001; Sasieni et al., 2009). The difficulty in detecting 
precursor glandular lesions, the fact that they are 
mostly asymptomatic lesions and the low sensitivity 
of cytology are cause of great concern (Ruba et al., 
2004). These lesions are often multifocal and there 
may be hidden disease in up to 60% of cases (Wright, 
2003). The definitive treatment of this pathology 
is by extra fascial hysterectomy (ACOG Practice 
Bulletin Number 131, 2012). Over the years, 
many studies have tried to find more conservative 
approaches, especially for young women who have 
not yet fulfilled their reproductive needs, such as 
cervical conisation, but interrogations persist about 
carcinological safety (Soutter et al., 2001; Graesslin 
et al., 2006; Munro et al., 2017).
There is already plenty of literature on the 
comparison between laparotomy and laparoscopy 
in the approach of cervical cancer (Ramirez et al., 
2006; Frumovitz et al., 2007; Malzoni et al., 2009; 
Pellegrino et al., 2009; Nam et al., 2012; Ghezzi et 
al., 2013). The benefits of laparoscopic surgery are 
undeniable, such as reduction of surgical trauma, 
less blood loss, precision in tissue manipulation, 
need for smaller incisions, less postoperative 
pain, faster patient recovery, shorter hospital stay 
and better aesthetic results in comparison to the 
conventional route (Koehler et al., 2012). As so, 
even radical hysterectomies are now performed by 
laparoscopy (Malzoni et al., 2009).
Nowadays, the technological development in this 
area has been such that it is already possible to use 
instruments of very small calibre, without disturbing 
the surgical technique (Ghezzi et al., 2011). Mini-
laparoscopy consists of the use of trocars of 3 mm 
or lower calibre, with the only possible exception 
being the umbilical port (Ghezzi et al., 2005; 2008; 
2009; Uccella et al., 2015; Setubal et al., 2017). 
Its advantages are related to the small incision 
sites, which result in a lower incidence of incision-
related complications, such as hernia, infection or 
pain (Novitsky et al., 2005; Yamamoto et al., 2011). 
The operative time does not seem to be augmented 
because of the use of these low calibre instruments 
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In the supra-pubic midline a 3.5 mm anciliary 
trocar was inserted (30114GZL; Karl Storz mini-
laparoscopy trocar set) to allow the use of the 3.5 
mm bipolar coagulator (Karl Storz Robi) and the 
mini-laparoscopic needle holder (Karl Storz mini-
laparoscopy set). The entire pelvis was inspected 
for invasive disease, which was not found. The end 
effectors were then introduced through the umbilical 
port and coupled to the rest of the instrument, with 
the possibility of changing the tool tips to grasp, cut, 
and manipulate tissue, as needed.
The procedure was undertaken using the 10 steps 
methodology: coagulation and section of the round 
ligament bilaterally; opening of the anterior leaf of 
the broad ligament; fenestration of the posterior leaf 
of broad ligaments to displace the ureter laterally; 
coagulation and section of the infundibulopelvic 
ligaments; coagulation and section of the utero-
ovarian ligaments bilaterally; vesical-uterine and 
posterior dissection; uterine vessels dissection, 
coagulation and section; opening of the vagina; 
uterus and adnexa extraction by vaginal route; 
vaginal closure with laparoscopic figure of eight 
sutures. In the uterine vascular pedicle, coagulation 
was made with a 3.5 mm bipolar grasper (Karl Storz 
Robi) and to close the vagina a mini-laparoscopic 
needle holder assisted by a PSS instrument.
The estimated blood loss was 30 mL and the 
operative time was 60 minutes. There were no 
intra or postoperative complications and the patient 
was discharged home 48 hours after surgery 
without pain. Post-operatively, she needed 1000 
mg of oral paracetamol 6 hours after the end of 
the procedure. No need to repeat the analgesia 
afterwards. On histology, there was evidence of 
low-grade squamous intraepithelial lesion, but with 
no evidence of glandular lesions. Post-operatively, 
the patient had a rapid recovery and she has been 
kept on follow-up with vaginal cytology, which was 
and it permits a refinement of the surgical 
movements (Fanfani et al., 2013). However, the 
use of 3 mm instruments has been limited by the 
required downsizing of the end effector, which 
compromises the strength that can be performed 
in procedures such as hysterectomy. To overcome 
this, instruments having a 2.9-mm shaft that are 
inserted percutaneously through the skin (like in 
a needle puncture) have been developed, having 
5 mm effector tips that can be inserted by a trocar 
of 5 or more mm and be coupled at the end of the 
instruments: the 2.9 mm Percuvance™ Percutaneous 
Surgical System (PSS) (The Percuvance™ System, 
Teleflex Inc., USA) (Chang et al., 2016). 
Our objective is to demonstrate the feasibility 
of the use of mini-laparoscopic hysterectomy 
interchangeable 5-mm end effectors in a case of 
adenocarcinoma in situ of the uterine cervix.
Case report
A 53-year-old otherwise healthy post-menopausal 
woman with no previous surgeries and a body mass 
index of 21 kg/m2 was referred to our department for 
atypical squamous cells of undetermined significance 
in the Pap smear with a human papillomavirus 
test positive for the genotype 16. The patient had 
no symptoms. She underwent colposcopy with 
biopsy and the result was cervical intraepithelial 
neoplasia type 1 with suspicion of a glandular 
lesion. Cervical conisation was made using LASER 
and the histology revealed adenocarcinoma in situ 
of the uterine cervix. Her transvaginal ultrasound 
was normal.
After discussion of the therapeutic options 
with the patient, it was decided to perform a total 
hysterectomy with bilateral adnexectomy. Given the 
fact that she was a healthy woman with no previous 
abdominal surgeries, the approach chosen was mini-
laparoscopy complemented with the Percuvance™ 
system (The Percuvance™ System, Teleflex Inc., 
USA) whose instruments are introduced through the 
abdominal wall without trocar.
A mini-laparoscopic hysterectomy was 
performed. Under general anaesthesia, the patient 
was placed in the dorsal decubitus position with 
her arms alongside her body and her lower limbs 
in abduction. Pneumoperitoneum was achieved 
using a Veress needle placed in her umbilicus. 
One 6-mm trocar was placed at the umbilicus for 
the zero-degree laparoscope; two shafts of 2.9 mm 
Percuvance™ Percutaneous Surgical System (PSS) 
(The Percuvance™ System, Teleflex Inc., USA) 
were then inserted under direct visualization, one 
at the right anterosuperior iliac spine and another 
at the left anterosuperior iliac spine (figure 1). 
Figure 1 – Mini-laparoscopic hysterectomy complemented 
with the Percuvance™ system (The Percuvance™ System, 
Teleflex Inc., USA)
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to maintain a standard setting and it represents a 
significant advance in minimally invasive surgery 
(Chang et al., 2016; Rossito et al., 2016; Romano 
et al., 2017). As described by other authors, we 
found that the Percuvance™ system was a good 
alternative to a 5-mm port, the change of the end 
effectors was technically simple and we did not 
experience any disengagement of instrument tips 
during this procedure. (Chang et al., 2016). The 
only handicap is the limited variety of end effectors 
currently available.
Surgeons need to adapt themselves to this rapidly-
changing world, deciding which new technology 
or technique they will adopt. The goal will be to 
make technology bring health benefits. We strongly 
believe that this was what happened with our 
patient, a healthy and asymptomatic woman who 
was cured from an oncologic disease, practically 
without having visible marks of the surgery she 
was submitted to. Some people may understand 
these marks as a pure aesthetic problem, but we 
believe this helps achieve a complete physical and 
psychological well-being.
Declaration of Interests: The authors report no 
declarations of interest and confirm that they have 
obtained the written permission of the patient whose 
case is being presented.
Conclusion
Percutaneous mini-laparoscopic hysterectomy is 
technically feasible and is a viable alternative to 
surgical treatment of women with adenocarcinoma 
in situ of the uterine cervix. It is never enough 
to emphasize its advantages, especially the 
minimization of surgical trauma, the refinement 
of the surgical movements and the higher patient 
satisfaction.
We hope our case to encourage more surgeons 
to learn and apply mini-laparoscopy, percutaneous 
systems and other new endoscopic techniques in 
favour of the patients.
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